Priti Kumar - Publications

Affiliations: 
Yale University, New Haven, CT 
Area:
Microbiology Biology, Virology Biology

40/110 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Ullah I, Escudie F, Scandale I, Gilani Z, Gendron-Lepage G, Gaudette F, Mowbray C, Fraisse L, Bazin R, Finzi A, Mothes W, Kumar P, Chatelain E, Uchil PD. Combinatorial Regimens Augment Drug Monotherapy for SARS-CoV-2 Clearance in Mice. Biorxiv : the Preprint Server For Biology. PMID 37398307 DOI: 10.1101/2023.05.31.543159  0.314
2022 Prévost J, Anand SP, Rajashekar JK, Zhu L, Richard J, Goyette G, Medjahed H, Gendron-Lepage G, Chen HC, Chen Y, Horwitz JA, Grunst MW, Zolla-Pazner S, Haynes BF, Burton DR, ... ... Kumar P, et al. HIV-1 Vpu restricts Fc-mediated effector functions in vivo. Cell Reports. 41: 111624. PMID 36351384 DOI: 10.1016/j.celrep.2022.111624  0.353
2020 Zhao Y, Amodio M, Vander Wyk B, Gerritsen B, Kumar MM, van Dijk D, Moon K, Wang X, Malawista A, Richards MM, Cahill ME, Desai A, Sivadasan J, Venkataswamy MM, Ravi V, ... ... Kumar P, et al. Single cell immune profiling of dengue virus patients reveals intact immune responses to Zika virus with enrichment of innate immune signatures. Plos Neglected Tropical Diseases. 14: e0008112. PMID 32150565 DOI: 10.1371/Journal.Pntd.0008112  0.463
2019 Ventura JD, Beloor J, Allen E, Zhang T, Haugh KA, Uchil PD, Ochsenbauer C, Kieffer C, Kumar P, Hope TJ, Mothes W. Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice. Plos Pathogens. 15: e1008161. PMID 31805155 DOI: 10.1371/Journal.Ppat.1008161  0.423
2019 Ullah I, Chung K, Beloor J, Lee SK, Kumar P. A Positioning Device for the Placement of Mice During Intranasal siRNA Delivery to the Central Nervous System. Journal of Visualized Experiments : Jove. PMID 31475960 DOI: 10.3791/59201  0.344
2019 Kumar P, Nagarajan A, Uchil PD. Introducing Genes into Cultured Mammalian Cells. Cold Spring Harbor Protocols. PMID 31285274 DOI: 10.1101/Pdb.Top095406  0.355
2019 Allen TM, Brehm MA, Bridges S, Ferguson S, Kumar P, Mirochnitchenko O, Palucka K, Pelanda R, Sanders-Beer B, Shultz LD, Su L, PrabhuDas M. Humanized immune system mouse models: progress, challenges and opportunities. Nature Immunology. PMID 31160798 DOI: 10.1038/S41590-019-0416-Z  0.329
2019 Kudalkar SN, Ullah I, Bertoletti N, Mandl HK, Cisneros JA, Beloor J, Chan AH, Quijano E, Saltzman WM, Jorgensen WL, Kumar P, Anderson KS. Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV. Antiviral Research. PMID 31034849 DOI: 10.1016/J.Antiviral.2019.04.010  0.38
2019 Kumar P, Nagarajan A, Uchil PD. DNA Transfection Mediated by Cationic Lipid Reagents. Cold Spring Harbor Protocols. 2019: pdb.prot095414. PMID 30824617 DOI: 10.1101/Pdb.Prot095414  0.316
2018 Kudalkar SN, Beloor J, Quijano E, Spasov KA, Lee WG, Cisneros JA, Saltzman WM, Kumar P, Jorgensen WL, Anderson KS. Reply to Pandey et al.: Understanding the efficacy of a potential antiretroviral drug candidate in humanized mouse model of HIV infection. Proceedings of the National Academy of Sciences of the United States of America. PMID 30097540 DOI: 10.1073/Pnas.1810136115  0.314
2018 Beloor J, Maes N, Ullah I, Uchil P, Jackson A, Fikrig E, Lee SK, Kumar P. Small Interfering RNA-Mediated Control of Virus Replication in the CNS Is Therapeutic and Enables Natural Immunity to West Nile Virus. Cell Host & Microbe. PMID 29606496 DOI: 10.1016/J.Chom.2018.03.001  0.557
2017 Kudalkar SN, Beloor J, Quijano E, Spasov KA, Lee WG, Cisneros JA, Saltzman WM, Kumar P, Jorgensen WL, Anderson KS. From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America. PMID 29279368 DOI: 10.1073/Pnas.1717932115  0.347
2017 Kudalkar SN, Beloor J, Chan AH, Lee WG, Jorgensen WL, Kumar P, Anderson KS. Structural and Preclinical Studies of Computationally-Designed Non-nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection. Molecular Pharmacology. PMID 28167742 DOI: 10.1124/Mol.116.107755  0.305
2016 Ullah I, Chung K, Beloor J, Kim J, Cho M, Kim N, Lee KY, Kumar P, Lee SK. Trileucine residues in a ligand-CPP-based siRNA delivery platform improve endosomal escape of siRNA. Journal of Drug Targeting. 1-29. PMID 27820977 DOI: 10.1080/1061186X.2016.1258566  0.358
2016 Bahal R, Ali McNeer N, Quijano E, Liu Y, Sulkowski P, Turchick A, Lu YC, Bhunia DC, Manna A, Greiner DL, Brehm MA, Cheng CJ, López-Giráldez F, Ricciardi A, Beloor J, ... ... Kumar P, et al. In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery. Nature Communications. 7: 13304. PMID 27782131 DOI: 10.1038/Ncomms13304  0.325
2015 Akkina RK, Allam A, Balazs AB, Blankson J, Burnett JC, Casares S, Garcia JV, Hasenkrug K, Kashanchi F, Kitchen S, Klein F, Kumar P, Luster AD, Poluektova LY, Rao M, et al. Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary. Aids Research and Human Retroviruses. PMID 26670361 DOI: 10.1089/Aid.2015.0258  0.347
2015 Sewald X, Ladinsky MS, Uchil PD, Beloor J, Pi R, Herrmann C, Motamedi N, Murooka TT, Brehm MA, Greiner DL, Shultz LD, Mempel TR, Bjorkman PJ, Kumar P, Mothes W. Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection. Science (New York, N.Y.). PMID 26429886 DOI: 10.1126/Science.Aab2749  0.414
2015 Beloor J, Zeller S, Choi CS, Lee SK, Kumar P. Cationic cell-penetrating peptides as vehicles for siRNA delivery. Therapeutic Delivery. 6: 491-507. PMID 25996046 DOI: 10.4155/Tde.15.2  0.36
2015 Liu S, Jackson A, Beloor J, Kumar P, Sutton R. Adenovirus-vectored broadly neutralizing antibodies directed against gp120 prevent HIV-1 acquisition in humanized mice. Human Gene Therapy. PMID 25953321 DOI: 10.1089/Hum.2014.146  0.378
2015 Deng K, Pertea M, Rongvaux A, Wang L, Durand CM, Ghiaur G, Lai J, McHugh HL, Hao H, Zhang H, Margolick JB, Gurer C, Murphy AJ, Valenzuela DM, Yancopoulos GD, ... ... Kumar P, et al. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature. 517: 381-5. PMID 25561180 DOI: 10.1038/Nature14053  0.428
2015 Beloor J, Ramakrishna S, Nam K, Seon Choi C, Kim J, Kim SH, Cho HJ, Shin H, Kim H, Kim SW, Lee SK, Kumar P. Effective gene delivery into human stem cells with a cell-targeting Peptide-modified bioreducible polymer. Small (Weinheim An Der Bergstrasse, Germany). 11: 2069-79. PMID 25515928 DOI: 10.1002/Smll.201402933  0.335
2014 Beloor J, Nam HY, Lee SK, Kumar P. Arginine-grafted biodegradable polymer: a versatile transfection reagent for both DNA and siRNA. Methods in Molecular Biology (Clifton, N.J.). 1176: 115-26. PMID 25030923 DOI: 10.1007/978-1-4939-0992-6_10  0.307
2013 Schleifman EB, McNeer NA, Jackson A, Yamtich J, Brehm MA, Shultz LD, Greiner DL, Kumar P, Saltzman WM, Glazer PM. Site-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized Mice. Molecular Therapy. Nucleic Acids. 2: e135. PMID 24253260 DOI: 10.1038/Mtna.2013.59  0.393
2013 McNeer NA, Schleifman EB, Cuthbert A, Brehm M, Jackson A, Cheng C, Anandalingam K, Kumar P, Shultz LD, Greiner DL, Mark Saltzman W, Glazer PM. Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo. Gene Therapy. 20: 658-69. PMID 23076379 DOI: 10.1038/Gt.2012.82  0.339
2012 Lee SK, Siefert A, Beloor J, Fahmy TM, Kumar P. Cell-specific siRNA delivery by peptides and antibodies. Methods in Enzymology. 502: 91-122. PMID 22208983 DOI: 10.1016/B978-0-12-416039-2.00005-7  0.343
2012 Beloor J, Choi CS, Nam HY, Park M, Kim SH, Jackson A, Lee KY, Kim SW, Kumar P, Lee SK. Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA. Biomaterials. 33: 1640-50. PMID 22112761 DOI: 10.1016/J.Biomaterials.2011.11.008  0.343
2011 Choi S, Lee J, Kumar P, Lee KY, Lee SK. Single chain variable fragment CD7 antibody conjugated PLGA/HDAC inhibitor immuno-nanoparticles: developing human T cell-specific nano-technology for delivery of therapeutic drugs targeting latent HIV. Journal of Controlled Release : Official Journal of the Controlled Release Society. 152: e9-10. PMID 22195949 DOI: 10.1016/J.Jconrel.2011.08.089  0.32
2011 Schleifman EB, Bindra R, Leif J, del Campo J, Rogers FA, Uchil P, Kutsch O, Shultz LD, Kumar P, Greiner DL, Glazer PM. Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids. Chemistry & Biology. 18: 1189-98. PMID 21944757 DOI: 10.1016/J.Chembiol.2011.07.010  0.398
2010 Kim SS, Ye C, Kumar P, Chiu I, Subramanya S, Wu H, Shankar P, Manjunath N. Targeted delivery of siRNA to macrophages for anti-inflammatory treatment. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 993-1001. PMID 20216529 DOI: 10.1038/Mt.2010.27  0.309
2010 Subramanya S, Kim SS, Abraham S, Yao J, Kumar M, Kumar P, Haridas V, Lee SK, Shultz LD, Greiner D, N M, Shankar P. Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production. Journal of Virology. 84: 2490-501. PMID 20015996 DOI: 10.1128/Jvi.02105-08  0.448
2010 Kim SS, Peer D, Kumar P, Subramanya S, Wu H, Asthana D, Habiro K, Yang YG, Manjunath N, Shimaoka M, Shankar P. RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 370-6. PMID 19997090 DOI: 10.1038/Mt.2009.271  0.466
2009 Lee SK, Kumar P. Conditional RNAi: towards a silent gene therapy. Advanced Drug Delivery Reviews. 61: 650-64. PMID 19394374 DOI: 10.1016/J.Addr.2009.03.016  0.32
2009 Kim S, Peer D, Kumar P, Shimaoka M, Shankar P. T.86. siRNA Delivery with Integrin LFA-1-targeted Nanoparticles Prevents HIV Infection in Humanized Mice Clinical Immunology. 131. DOI: 10.1016/J.Clim.2009.03.221  0.368
2008 Kumar P, Ban HS, Kim SS, Wu H, Pearson T, Greiner DL, Laouar A, Yao J, Haridas V, Habiro K, Yang YG, Jeong JH, Lee KY, Kim YH, Kim SW, et al. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell. 134: 577-86. PMID 18691745 DOI: 10.1016/J.Cell.2008.06.034  0.431
2008 Son J, Uchil PD, Kim YB, Shankar P, Kumar P, Lee SK. Effective suppression of HIV-1 by artificial bispecific miRNA targeting conserved sequences with tolerance for wobble base-pairing. Biochemical and Biophysical Research Communications. 374: 214-8. PMID 18619945 DOI: 10.1016/J.Bbrc.2008.06.125  0.332
2007 Kumar P, Wu H, McBride JL, Jung KE, Kim MH, Davidson BL, Lee SK, Shankar P, Manjunath N. Transvascular delivery of small interfering RNA to the central nervous system. Nature. 448: 39-43. PMID 17572664 DOI: 10.1038/Nature05901  0.379
2006 Manjunath N, Kumar P, Lee SK, Shankar P. Interfering antiviral immunity: application, subversion, hope? Trends in Immunology. 27: 328-35. PMID 16753342 DOI: 10.1016/J.It.2006.05.006  0.439
2006 Kumar P, Lee SK, Shankar P, Manjunath N. A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. Plos Medicine. 3: e96. PMID 16464133 DOI: 10.1371/Journal.Pmed.0030096  0.418
2005 Lee SK, Dykxhoorn DM, Kumar P, Ranjbar S, Song E, Maliszewski LE, François-Bongarçon V, Goldfeld A, Swamy NM, Lieberman J, Shankar P. Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood. 106: 818-26. PMID 15831707 DOI: 10.1182/Blood-2004-10-3959  0.324
2004 Kumar P, Krishna VD, Sulochana P, Nirmala G, Haridattatreya M, Satchidanandam V. Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain. The Journal of General Virology. 85: 471-82. PMID 14769905 DOI: 10.1099/vir.0.19531-0  0.366
Low-probability matches (unlikely to be authored by this person)
2021 Ullah I, Prévost J, Ladinsky MS, Stone H, Lu M, Anand SP, Beaudoin-Bussières G, Benlarbi M, Ding S, Gasser R, Fink C, Chen Y, Tauzin A, Goyette G, Bourassa C, ... ... Kumar P, et al. Live imaging of SARS-CoV-2 infection in mice reveals neutralizing antibodies require Fc function for optimal efficacy. Biorxiv : the Preprint Server For Biology. PMID 33791699 DOI: 10.1101/2021.03.22.436337  0.3
2024 Ullah I, Escudie F, Scandale I, Gilani Z, Gendron-Lepage G, Gaudette F, Mowbray C, Fraisse L, Bazin R, Finzi A, Mothes W, Kumar P, Chatelain E, Uchil PD. Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens. Iscience. 27: 109049. PMID 38361624 DOI: 10.1016/j.isci.2024.109049  0.294
2015 Zeller S, Choi CS, Uchil PD, Ban HS, Siefert A, Fahmy TM, Mothes W, Lee SK, Kumar P. Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA. Chemistry & Biology. 22: 50-62. PMID 25544044 DOI: 10.1016/J.Chembiol.2014.11.009  0.288
2021 Ullah I, Prévost J, Ladinsky MS, Stone H, Lu M, Anand SP, Beaudoin-Bussières G, Symmes K, Benlarbi M, Ding S, Gasser R, Fink C, Chen Y, Tauzin A, Goyette G, ... ... Kumar P, et al. Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy. Immunity. PMID 34453881 DOI: 10.1016/j.immuni.2021.08.015  0.287
2021 Haugh KA, Ladinsky MS, Ullah I, Stone HM, Pi R, Gilardet A, Grunst MW, Kumar P, Bjorkman PJ, Mothes W, Uchil PD. imaging of retrovirus infection reveals a role for Siglec-1/CD169 in multiple routes of transmission. Elife. 10. PMID 34223819 DOI: 10.7554/eLife.64179  0.286
2023 Behrens RT, Rajashekar JK, Bruce JW, Evans EL, Hansen AM, Salazar-Quiroz N, Simons LM, Ahlquist P, Hultquist JF, Kumar P, Sherer NM. Exploiting a rodent cell block for intrinsic resistance to HIV-1 gene expression in human T cells. Mbio. e0042023. PMID 37676006 DOI: 10.1128/mbio.00420-23  0.286
2019 Kumar P, Nagarajan A, Uchil PD. Calcium Phosphate-Mediated Transfection of Adherent Cells or Cells Growing in Suspension: Variations on the Basic Method. Cold Spring Harbor Protocols. 2019: pdb.prot095455. PMID 31575795 DOI: 10.1101/Pdb.Prot095455  0.286
2020 Ullah I, Chung K, Bae S, Li Y, Kim C, Choi B, Nam HY, Kim SH, Yun CO, Lee KY, Kumar P, Lee SK. Nose-to-Brain Delivery of Cancer-Targeting Paclitaxel-loaded Nanoparticles Potentiates Anti-Tumor Effects in Malignant Glioblastoma. Molecular Pharmaceutics. PMID 31944768 DOI: 10.1021/Acs.Molpharmaceut.9B01215  0.285
2019 Chung K, Ullah I, Kim N, Lim J, Shin J, Lee SC, Jeon S, Kim SH, Kumar P, Lee SK. Intranasal delivery of cancer-targeting doxorubicin-loaded PLGA nanoparticle arrests glioblastoma growth. Journal of Drug Targeting. 1-28. PMID 31852284 DOI: 10.1080/1061186X.2019.1706095  0.282
2018 Kumar P, Nagarajan A, Uchil PD. Selective Agents for Stable Transfection. Cold Spring Harbor Protocols. 2018: pdb.top096230. PMID 30181228 DOI: 10.1101/Pdb.Top096230  0.28
2019 Kumar P, Nagarajan A, Uchil PD. DNA Transfection by Electroporation. Cold Spring Harbor Protocols. 2019: pdb.prot095471. PMID 31262956 DOI: 10.1101/Pdb.Prot095471  0.28
2016 Kim J, Chung K, Choi C, Beloor J, Ullah I, Kim N, Lee KY, Lee SK, Kumar P. Silencing CCR2 in Macrophages Alleviates Adipose Tissue Inflammation and the Associated Metabolic Syndrome in Dietary Obese Mice. Molecular Therapy. Nucleic Acids. 5: e280. PMID 26812653 DOI: 10.1038/Mtna.2015.51  0.28
2012 Kim SS, Kumar P, Ye C, Shankar P. Humanized mice for studying human leukocyte integrins in vivo. Methods in Molecular Biology (Clifton, N.J.). 757: 509-21. PMID 21909931 DOI: 10.1007/978-1-61779-166-6_30  0.28
2018 Kumar P, Nagarajan A, Uchil PD. Analysis of Cell Viability by the Lactate Dehydrogenase Assay. Cold Spring Harbor Protocols. 2018: pdb.prot095497. PMID 29858337 DOI: 10.1101/Pdb.Prot095497  0.277
2018 Kumar P, Nagarajan A, Uchil PD. DEAE-Dextran Transfection. Cold Spring Harbor Protocols. 2018: pdb.top096263. PMID 29967279 DOI: 10.1101/Pdb.Top096263  0.277
2019 Kumar P, Nagarajan A, Uchil PD. Calcium Phosphate-Mediated Transfection of Eukaryotic Cells with Plasmid DNAs. Cold Spring Harbor Protocols. 2019: pdb.prot095430. PMID 31575793 DOI: 10.1101/Pdb.Prot095430  0.276
2018 Kumar P, Nagarajan A, Uchil PD. Analysis of Cell Viability by the MTT Assay. Cold Spring Harbor Protocols. 2018: pdb.prot095505. PMID 29858338 DOI: 10.1101/Pdb.Prot095505  0.276
2018 Ullah I, Chung K, Oh J, Beloor J, Bae S, Lee SC, Lee M, Kumar P, Lee SK. Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemia. Scientific Reports. 8: 15041. PMID 30301943 DOI: 10.1038/S41598-018-33296-Z  0.274
2020 Kim N, Ullah I, Chung K, Lee D, Cha MJ, Ban H, Choi CS, Kim S, Hwang KC, Kumar P, Lee SK. Targeted delivery of recombinant heat shock protein 27 to cardiomyocytes promotes recovery from myocardial infarction. Molecular Pharmaceutics. PMID 32364395 DOI: 10.1021/Acs.Molpharmaceut.0C00192  0.271
2021 Rajashekar JK, Richard J, Beloor J, Prévost J, Anand SP, Beaudoin-Bussières G, Shan L, Herndler-Brandstetter D, Gendron-Lepage G, Medjahed H, Bourassa C, Gaudette F, Ullah I, Symmes K, Peric A, ... ... Kumar P, et al. Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir. Cell Host & Microbe. PMID 34019804 DOI: 10.1016/j.chom.2021.04.014  0.271
2018 Kumar P, Nagarajan A, Uchil PD. Transfection Mediated by DEAE-Dextran. Cold Spring Harbor Protocols. 2018: pdb.prot095463. PMID 29967275 DOI: 10.1101/Pdb.Prot095463  0.269
2017 Uchil PD, Nagarajan A, Kumar P. Assay for β-Galactosidase in Extracts of Mammalian Cells. Cold Spring Harbor Protocols. 2017: pdb.prot095778. PMID 28974657 DOI: 10.1101/Pdb.Prot095778  0.266
2018 Kumar P, Nagarajan A, Uchil PD. Analysis of Cell Viability by the alamarBlue Assay. Cold Spring Harbor Protocols. 2018: pdb.prot095489. PMID 29858336 DOI: 10.1101/Pdb.Prot095489  0.262
2019 Kumar P, Nagarajan A, Uchil PD. Histochemical Staining of Cell Monolayers for β-Galactosidase. Cold Spring Harbor Protocols. 2019: pdb.prot095422. PMID 30824618 DOI: 10.1101/Pdb.Prot095422  0.261
2019 Kumar P, Nagarajan A, Uchil PD. Transfection of Mammalian Cells with Calcium Phosphate-DNA Coprecipitates. Cold Spring Harbor Protocols. 2019: pdb.top096255. PMID 31575800 DOI: 10.1101/Pdb.Top096255  0.259
2019 Amodio M, van Dijk D, Srinivasan K, Chen WS, Mohsen H, Moon KR, Campbell A, Zhao Y, Wang X, Venkataswamy M, Desai A, Ravi V, Kumar P, Montgomery R, Wolf G, et al. Exploring single-cell data with deep multitasking neural networks. Nature Methods. PMID 31591579 DOI: 10.1038/S41592-019-0576-7  0.254
2006 Satchidanandam V, Uchil PD, Kumar P. Organization of flaviviral replicase proteins in virus-induced membranes: a role for NS1' in Japanese encephalitis virus RNA synthesis. Novartis Foundation Symposium. 277: 136-45; discussion 1. PMID 17319159  0.252
2023 Lyons DE, Kumar P, Roan NR, Defechereux PA, Feschotte C, Lange UC, Murthy N, Sameshima P, Verdin E, Ake JA, Parsons MS, Nath A, Gianella S, Smith DM, Kallas EG, et al. HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing. Viruses. 15. PMID 38005849 DOI: 10.3390/v15112171  0.247
2009 Ban HS, Lee SK, Kumar P. Delivering antiviral siRNA into human T-cells: New approaches in RNAi-based HIV therapy. Idrugs : the Investigational Drugs Journal. 12: 774-8. PMID 19943220  0.242
2013 Augagneur Y, Jaubert L, Schiavoni M, Pachikara N, Garg A, Usmani-Brown S, Wesolowski D, Zeller S, Ghosal A, Cornillot E, Said HM, Kumar P, Altman S, Ben Mamoun C. Identification and functional analysis of the primary pantothenate transporter, PfPAT, of the human malaria parasite Plasmodium falciparum. The Journal of Biological Chemistry. 288: 20558-67. PMID 23729665 DOI: 10.1074/Jbc.M113.482992  0.241
2022 Beaudoin-Bussières G, Chen Y, Ullah I, Prévost J, Tolbert WD, Symmes K, Ding S, Benlarbi M, Gong SY, Tauzin A, Gasser R, Chatterjee D, Vézina D, Goyette G, Richard J, ... ... Kumar P, et al. A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection. Cell Reports. 38: 110368. PMID 35123652 DOI: 10.1016/j.celrep.2022.110368  0.24
2019 Kumar P, Nagarajan A, Uchil PD. Calcium Phosphate-Mediated Transfection of Cells with High-Molecular-Weight Genomic DNA. Cold Spring Harbor Protocols. 2019: pdb.prot095448. PMID 31575794 DOI: 10.1101/Pdb.Prot095448  0.24
2022 Ding S, Ullah I, Gong SY, Grover J, Mohammadi M, Chen Y, Vézina D, Beaudoin-Bussières G, Verma VT, Goyette G, Gaudette F, Richard J, Yang D, Smith AB, Pazgier M, ... ... Kumar P, et al. VE607 Stabilizes SARS-CoV-2 Spike In the "RBD-up" Conformation and Inhibits Viral Entry. Iscience. 104528. PMID 35677392 DOI: 10.1016/j.isci.2022.104528  0.232
2021 Chen Y, Sun L, Ullah I, Beaudoin-Bussières G, Anand SP, Hederman AP, Tolbert WD, Sherburn R, Nguyen DN, Marchitto L, Ding S, Wu D, Luo Y, Gottumukkala S, Moran S, ... Kumar P, et al. Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities. Biorxiv : the Preprint Server For Biology. PMID 34845451 DOI: 10.1101/2021.11.24.469776  0.232
2023 Lorenzo MM, Marín-López A, Chiem K, Jimenez-Cabello L, Ullah I, Utrilla-Trigo S, Calvo-Pinilla E, Lorenzo G, Moreno S, Ye C, Park JG, Matía A, Brun A, Sánchez-Puig JM, Nogales A, ... ... Kumar P, et al. Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models. Vaccines. 11. PMID 37243110 DOI: 10.3390/vaccines11051006  0.227
2022 Beloor J, Kudalkar SN, Buzzelli G, Yang F, Mandl HK, Rajashekar JK, Spasov KA, Jorgensen WL, Saltzman WM, Anderson KS, Kumar P. Long-acting and extended-release implant and nanoformulations with a synergistic antiretroviral two-drug combination controls HIV-1 infection in a humanized mouse model. Bioengineering & Translational Medicine. 7: e10237. PMID 35079625 DOI: 10.1002/btm2.10237  0.224
2004 Kumar P, Sulochana P, Nirmala G, Chandrashekar R, Haridattatreya M, Satchidanandam V. Impaired T helper 1 function of nonstructural protein 3-specific T cells in Japanese patients with encephalitis with neurological sequelae. The Journal of Infectious Diseases. 189: 880-91. PMID 14976606 DOI: 10.1086/381768  0.224
2007 Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA, Manjunath N. miRNA profiling of naïve, effector and memory CD8 T cells. Plos One. 2: e1020. PMID 17925868 DOI: 10.1371/Journal.Pone.0001020  0.223
2017 Nagarajan A, Dogra SK, Sun L, Gandotra N, Ho T, Cai G, Cline G, Kumar P, Cowles RA, Wajapeyee N. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport. Molecular Cell. PMID 28803777 DOI: 10.1016/J.Molcel.2017.07.014  0.223
2011 Zeller SJ, Kumar P. RNA-based gene therapy for the treatment and prevention of HIV: from bench to bedside. The Yale Journal of Biology and Medicine. 84: 301-9. PMID 21966049  0.218
2022 Chen Y, Sun L, Ullah I, Beaudoin-Bussières G, Anand SP, Hederman AP, Tolbert WD, Sherburn R, Nguyen DN, Marchitto L, Ding S, Wu D, Luo Y, Gottumukkala S, Moran S, ... Kumar P, et al. Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities. Science Advances. 8: eabn4188. PMID 35857504 DOI: 10.1126/sciadv.abn4188  0.213
2016 Zurnic I, Hütter S, Lehmann U, Stanke N, Reh J, Kern T, Lindel F, Gerresheim G, Hamann M, Müllers E, Lesbats P, Cherepanov P, Serrao E, Engelman A, Lindemann D, ... ... Kumar P, et al. Proceedings of the Frontiers of Retrovirology Conference 2016 Retrovirology. 13. DOI: 10.1186/S12977-016-0294-5  0.199
2022 Ullah I, Beaudoin-Bussières G, Symmes K, Cloutier M, Ducas E, Tauzin A, Laumaea A, Grunst MW, Dionne K, Richard J, Bégin P, Mothes W, Kumar P, Bazin R, Finzi A, et al. The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice. Cell Reports. Medicine. 100893. PMID 36584683 DOI: 10.1016/j.xcrm.2022.100893  0.199
2024 Papini C, Ullah I, Ranjan AP, Zhang S, Wu Q, Spasov KA, Zhang C, Mothes W, Crawford JM, Lindenbach BD, Uchil PD, Kumar P, Jorgensen WL, Anderson KS. Proof-of-concept studies with a computationally designed M inhibitor as a synergistic combination regimen alternative to Paxlovid. Proceedings of the National Academy of Sciences of the United States of America. 121: e2320713121. PMID 38621119 DOI: 10.1073/pnas.2320713121  0.198
1997 Yang J, Kumar P, Dimmock JR, Quail JW. 1,5-Bis[4,4-dimethyl-1-(4-methylphenyl)-5-(1-piperidinio)-1-penten-3-ylidene]carbonohydrazide Dichloride Methanol Solvate Acta Crystallographica Section C Crystal Structure Communications. 53: 140-143. DOI: 10.1107/S0108270196012607  0.197
2018 Kumar P, Nagarajan A, Uchil PD. Optical Transfection. Cold Spring Harbor Protocols. 2018: pdb.top096222. PMID 30510131 DOI: 10.1101/pdb.top096222  0.19
2023 Grandi A, Tomasi M, Ullah I, Bertelli C, Vanzo T, Accordini S, Gagliardi A, Zanella I, Benedet M, Corbellari R, Lascio GD, Tamburini S, Caproni E, Croia L, Ravà M, ... ... Kumar P, et al. Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine. Research Square. PMID 37292970 DOI: 10.21203/rs.3.rs-2788726/v1  0.185
2023 Grandi A, Tomasi M, Ullah I, Bertelli C, Vanzo T, Accordini S, Gagliardi A, Zanella I, Benedet M, Corbellari R, Di Lascio G, Tamburini S, Caproni E, Croia L, Ravà M, ... ... Kumar P, et al. Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine. Vaccines. 11. PMID 37896949 DOI: 10.3390/vaccines11101546  0.179
2024 Zhang N, Tang W, Torres L, Wang X, Ajaj Y, Zhu L, Luan Y, Zhou H, Wang Y, Zhang D, Kurbatov V, Khan SA, Kumar P, Hidalgo A, Wu D, et al. Cell surface RNAs control neutrophil recruitment. Cell. PMID 38262409 DOI: 10.1016/j.cell.2023.12.033  0.178
2022 Chen Y, Prévost J, Ullah I, Romero H, Lisi V, Tolbert WD, Grover JR, Ding S, Gong SY, Beaudoin-Bussières G, Gasser R, Benlarbi M, Vézina D, Anand SP, Chatterjee D, ... ... Kumar P, et al. Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBD. Iscience. 105783. PMID 36514310 DOI: 10.1016/j.isci.2022.105783  0.177
2004 Kumar P, Sulochana P, Nirmala G, Haridattatreya M, Satchidanandam V. Conserved amino acids 193-324 of non-structural protein 3 are a dominant source of peptide determinants for CD4+ and CD8+ T cells in a healthy Japanese encephalitis virus-endemic cohort. The Journal of General Virology. 85: 1131-43. PMID 15105530 DOI: 10.1099/vir.0.19698-0  0.17
2019 Kumar P, Nagarajan A, Uchil PD. Lipofection. Cold Spring Harbor Protocols. 2019: pdb.top096248. PMID 30824627 DOI: 10.1101/pdb.top096248  0.165
2003 Kumar P, Amara RR, Challu VK, Chadda VK, Satchidanandam V. The Apa protein of Mycobacterium tuberculosis stimulates gamma interferon-secreting CD4+ and CD8+ T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model. Infection and Immunity. 71: 1929-37. PMID 12654810  0.163
2021 Li W, Chen Y, Prévost J, Ullah I, Lu M, Gong SY, Tauzin A, Gasser R, Vézina D, Anand SP, Goyette G, Chaterjee D, Ding S, Tolbert WD, Grunst MW, ... ... Kumar P, et al. Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern. Biorxiv : the Preprint Server For Biology. PMID 34373853 DOI: 10.1101/2021.08.02.454546  0.159
2021 Li W, Chen Y, Prévost J, Ullah I, Lu M, Gong SY, Tauzin A, Gasser R, Vézina D, Anand SP, Goyette G, Chaterjee D, Ding S, Tolbert WD, Grunst MW, ... ... Kumar P, et al. Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern. Cell Reports. 110210. PMID 34971573 DOI: 10.1016/j.celrep.2021.110210  0.156
2004 Oravecz-Wilson KI, Kiel MJ, Li L, Rao DS, Saint-Dic D, Kumar PD, Provot MM, Hankenson KD, Reddy VN, Lieberman AP, Morrison SJ, Ross TS. Huntingtin Interacting Protein 1 mutations lead to abnormal hematopoiesis, spinal defects and cataracts. Human Molecular Genetics. 13: 851-67. PMID 14998932 DOI: 10.1093/Hmg/Ddh102  0.126
2003 Rao DS, Bradley SV, Kumar PD, Hyun TS, Saint-Dic D, Oravecz-Wilson K, Kleer CG, Ross TS. Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells. Cancer Cell. 3: 471-82. PMID 12781365 DOI: 10.1016/S1535-6108(03)00107-7  0.101
2020 Shah P, Kumar P, Gupta M, Gadam M, Ganla K, Kumar P, Satija R, Kale A, Chandra S. Probiotics for woman’s health focus on urogenital infections and reproductive outcomes International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 9: 884. DOI: 10.18203/2320-1770.ijrcog20200401  0.094
2004 Hyun TS, Rao DS, Saint-Dic D, Michael LE, Kumar PD, Bradley SV, Mizukami IF, Oravecz-Wilson KI, Ross TS. HIP1 and HIP1r stabilize receptor tyrosine kinases and bind 3-phosphoinositides via epsin N-terminal homology domains. The Journal of Biological Chemistry. 279: 14294-306. PMID 14732715 DOI: 10.1074/Jbc.M312645200  0.078
2002 Rao DS, Hyun TS, Kumar PD, Mizukami IF, Rubin MA, Lucas PC, Sanda MG, Ross TS. Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival. The Journal of Clinical Investigation. 110: 351-60. PMID 12163454 DOI: 10.1172/Jci200215529  0.062
2019 Kumar P, Nagarajan A, Uchil PD. Electroporation. Cold Spring Harbor Protocols. 2019: pdb.top096271. PMID 31262965 DOI: 10.1101/pdb.top096271  0.06
2018 Kumar A, Kumar P. Multi-component botanical drugs for degenerative diseases Clinical Trials in Degenerative Diseases. 3: 115. DOI: 10.4103/2542-3975.242960  0.052
2021 Kumar P, Arya S, Singh SK, Kumar S. The effect of clonidine with bupivacaine on perioperative hemodynamics and post-operative analgesia in cesarean section cases International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 10: 3049. DOI: 10.18203/2320-1770.ijrcog20212952  0.046
2017 Uchil PD, Nagarajan A, Kumar P. β-Galactosidase. Cold Spring Harbor Protocols. 2017: pdb.top096198. PMID 28974659 DOI: 10.1101/pdb.top096198  0.045
2017 Divakar H, Kumar P, Bansal K, Tripathi P, Dutta S, Manyonda I. POSTPARTUM PERIOD- A WINDOW OF OPPORTUNITY FOR ANAEMIA CORRECTION Journal of Evidence Based Medicine and Healthcare. 4: 228-232. DOI: 10.18410/jebmh/2017/44  0.036
2022 Kumar P, Shah P, Awasthi V, Khera B, Agarwal M, Lakhtakia M, Kumar D. Anemia in Pregnancy: A knowledge, Attitude and Practice Survey Amongst Obstetricians and Gynaecologists in India. Journal of Obstetrics and Gynaecology of India. 72: 382-388. PMID 36458064 DOI: 10.1007/s13224-022-01618-x  0.027
2003 Caussy D, Kumar P, Than Sein U. Health impact assessment needs in south-east Asian countries. Bulletin of the World Health Organization. 81: 439-43. PMID 12894329  0.025
2020 Kumar P, Patra S. A study on elder abuse in an urban resettlement colony of Delhi. Journal of Family Medicine and Primary Care. 8: 621-625. PMID 30984684 DOI: 10.4103/jfmpc.jfmpc_323_17  0.021
2018 Singh GN, Agarwal A, Jain V, Kumar P. Understanding and Practices of Gynaecologists Related to Breast Cancer Screening, Detection, Treatment and Common Breast Diseases: A Study from India. World Journal of Surgery. PMID 30051242 DOI: 10.1007/s00268-018-4740-5  0.018
1989 Kumar P, Dutt B. Cytogenetic basis of breeding system in some verbenaceous species. Cytologia. 54: 347-353. DOI: 10.1508/CYTOLOGIA.54.347  0.01
Hide low-probability matches.